| Year |
Citation |
Score |
| 2024 |
Facal CL, Fernández Bessone I, Muñiz JA, Pereyra AE, Pedroncini O, Páez-Paz I, Clerici-Delville R, Arnaiz C, Urrutia L, Falasco G, Argañaraz CV, Saez T, Marin-Burgin A, Soiza-Reilly M, Falzone T, et al. Tau reduction with artificial microRNAs modulates neuronal physiology and improves tauopathy phenotypes in mice. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 38310353 DOI: 10.1016/j.ymthe.2024.01.033 |
0.721 |
|
| 2022 |
Karmirian K, Holubiec M, Goto-Silva L, Fernandez Bessone I, Vitória G, Mello B, Alloatti M, Vanderborght B, Falzone TL, Rehen S. Modeling Alzheimer's Disease Using Human Brain Organoids. Methods in Molecular Biology (Clifton, N.J.). 2561: 135-158. PMID 36399268 DOI: 10.1007/978-1-0716-2655-9_7 |
0.661 |
|
| 2022 |
Fernandez Bessone I, Navarro J, Martinez E, Karmirian K, Holubiec M, Alloatti M, Goto-Silva L, Arnaiz Yepez C, Martins-de-Souza D, Nascimento JM, Bruno L, Saez TM, Rehen SK, Falzone TL. DYRK1A regulates the bidirectional axonal transport of APP in human-derived neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 35803734 DOI: 10.1523/JNEUROSCI.2551-21.2022 |
0.796 |
|
| 2020 |
Saez TM, Fernandez Bessone I, Rodriguez MS, Alloatti M, Otero MG, Cromberg LE, Pozo Devoto VM, Oubiña G, Sosa L, Buffone MG, Gelman DM, Falzone TL. Kinesin-1-mediated axonal transport of CB1 receptors is required for cannabinoid-dependent axonal growth and guidance. Development (Cambridge, England). PMID 32265198 DOI: 10.1242/Dev.184069 |
0.544 |
|
| 2018 |
Otero MG, Fernandez Bessone I, Hallberg AE, Cromberg LE, De Rossi MC, Saez TM, Levi V, Almenar-Queralt A, Falzone TL. Proteasome stress leads to APP axonal transport defects by promoting its amyloidogenic processing in lysosomes. Journal of Cell Science. 131. PMID 29724915 DOI: 10.1242/Jcs.214536 |
0.637 |
|
| Show low-probability matches. |